{"id":33707,"date":"2020-08-27T12:41:42","date_gmt":"2020-08-27T11:41:42","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=33707"},"modified":"2023-05-03T22:11:46","modified_gmt":"2023-05-03T21:11:46","slug":"donovan-yeates","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/donovan-yeates\/","title":{"rendered":"Donovan Yeates"},"content":{"rendered":"<div class=\"vgblk-rw-wrapper limit-wrapper\">\n\n\t<h2>Donovan B. Yeates<\/h2>\n<h4>CEO at KAER Biotherapeutics Corporation<\/h4>\n\t<p>Donovan B. Yeates, Ph.D., CEO, KAER Biotherapeutics Corporation, is an internationally recognized authority in aerosol drug delivery and respiratory function. Has developed technologies to deliver aerosols to the lungs, quantify the dose delivered and evaluate the physiological mechanisms whereby they are cleared from the lungs. He is an inventor of aerosol generation and delivery technology to deliver fine particle solid-phase aerosols from viscous solutions at high dose rates. Dr. Yeates is an emeritus professor with over 90 publications and 16 patents. He has a Ph.D. in Medical Biophysics from the University of Toronto.<\/p>\n\t\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Donovan_Yeates_Kaer_Biotherapeutics_BioTech_Pharma_summit_1.jpg\" alt=\"Donovan_Yeates_Kaer_Biotherapeutics_BioTech_Pharma_summit_1\" itemprop=\"image\" height=\"1224\" width=\"820\" title=\"Donovan_Yeates_Kaer_Biotherapeutics_BioTech_Pharma_summit_1\" onerror=\"this.style.display='none'\"  sizes=\"auto, (max-width: 768px) 100vw, 100vw\" srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Donovan_Yeates_Kaer_Biotherapeutics_BioTech_Pharma_summit_1.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Donovan_Yeates_Kaer_Biotherapeutics_BioTech_Pharma_summit_1-201x300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Donovan_Yeates_Kaer_Biotherapeutics_BioTech_Pharma_summit_1-686x1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Donovan_Yeates_Kaer_Biotherapeutics_BioTech_Pharma_summit_1-768x1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Donovan_Yeates_Kaer_Biotherapeutics_BioTech_Pharma_summit_1-630x940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Donovan_Yeates_Kaer_Biotherapeutics_BioTech_Pharma_summit_1-420x627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Donovan_Yeates_Kaer_Biotherapeutics_BioTech_Pharma_summit_1-315x470.jpg 315w\" \/>\t\t\t\t\t\t\t\n<h3>\n\tTitle: Delivery of Therapeutic Aerosols to Critically Ill Patients\n\t<\/h3>\n<div class=\"su-expand su-expand-collapsed su-expand-link-style-default\" data-height=\"150\"><div class=\"su-expand-content su-u-trim\" style=\"color:#333333;max-height:150px;overflow:hidden\">\n<ul>\n<li>The delivery therapeutically relevant doses of anti-infectives, surfactant and anticancer agents to the peripheral lung in patients with serve respiratory impairment has been a recalcitrant issue in both spontaneously breathing patients and those on respiratory support. The issues of lung congestion, respiratory insufficiency and device interaction will be introduced<\/li>\n<li>A decision tree will be presented that addresses the issues related to the choice of aerosol delivery device suitable for critically ill patients. This will include the delivery of aqueous and solid-phase aerosols. Attention will be given to the device-patient interface<\/li>\n<li>The development of new device technologies and patient interfaces as well as the potential of heliox to improve aerosol generation, delivery and peripheral deposition will be presented<\/li>\n<\/ul>\n<\/div><div class=\"su-expand-link su-expand-link-more\" style=\"text-align:left\"><a href=\"javascript:;\" style=\"color:#0088FF;border-color:#0088FF\"><span style=\"border-color:#0088FF\">Show more<\/span><\/a><\/div><div class=\"su-expand-link su-expand-link-less\" style=\"text-align:left\"><a href=\"javascript:;\" style=\"color:#0088FF;border-color:#0088FF\"><span style=\"border-color:#0088FF\">Show less<\/span><\/a><\/div><\/div>\n\t<a href=\"https:\/\/sociopharma.com\/\" target=\"_blank\" role=\"button\" rel=\"noopener\">\n\t\t\t\t\tPresentation available only at SocioPharma.com\n\t<\/a>\n<h4>\n\t\t\t<a href=\"#\" title=\"On the Web\" target=\"_self\" rel=\"noopener\">\n\tOn the Web\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.kaerbio.com\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.kaerbio.com\/<\/a><\/p>\n<h4>\n\t\t\t<a href=\"#\" title=\"On LinkedIn\" target=\"_self\" rel=\"noopener\">\n\tOn LinkedIn\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.linkedin.com\/in\/donovan-yeates\" target=\"_blank\" rel=\"noopener\">Visit Profile<\/a><\/p>\n\n<\/div><!-- .vgblk-rw-wrapper -->","protected":false},"excerpt":{"rendered":"<p>Donovan B. Yeates CEO at KAER Biotherapeutics Corporation Donovan B. Yeates, Ph.D., CEO, KAER Biotherapeutics Corporation, is an internationally recognized authority in aerosol drug delivery and respiratory function. Has developed technologies to deliver aerosols to the lungs, quantify the dose delivered and evaluate the physiological mechanisms whereby they are cleared from the lungs. He is&#8230;<\/p>\n","protected":false},"author":1,"featured_media":33708,"parent":33607,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-33707","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Donovan Yeates &#8226; BioTech Pharma Summit<\/title>\n<meta name=\"description\" content=\"Donovan B. Yeates, Ph.D., CEO, KAER Biotherapeutics Corporation, is an internationally recognized authority in aerosol drug delivery and respiratory function.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/donovan-yeates\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Donovan Yeates &#8226; BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"Donovan B. Yeates, Ph.D., CEO, KAER Biotherapeutics Corporation, is an internationally recognized authority in aerosol drug delivery and respiratory function.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/donovan-yeates\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-03T21:11:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Donovan_Yeates_Kaer_Biotherapeutics_BioTech_Pharma_summit.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/donovan-yeates\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/donovan-yeates\/\",\"name\":\"Donovan Yeates &#8226; BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/donovan-yeates\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/donovan-yeates\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Donovan_Yeates_Kaer_Biotherapeutics_BioTech_Pharma_summit.jpg\",\"datePublished\":\"2020-08-27T11:41:42+00:00\",\"dateModified\":\"2023-05-03T21:11:46+00:00\",\"description\":\"Donovan B. Yeates, Ph.D., CEO, KAER Biotherapeutics Corporation, is an internationally recognized authority in aerosol drug delivery and respiratory function.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/donovan-yeates\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/donovan-yeates\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/donovan-yeates\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Donovan_Yeates_Kaer_Biotherapeutics_BioTech_Pharma_summit.jpg\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Donovan_Yeates_Kaer_Biotherapeutics_BioTech_Pharma_summit.jpg\",\"width\":900,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/donovan-yeates\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Inhalation &#038; Respiratory Drug Delivery 2019 Speakers\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Donovan Yeates\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow&#039;s healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Donovan Yeates &#8226; BioTech Pharma Summit","description":"Donovan B. Yeates, Ph.D., CEO, KAER Biotherapeutics Corporation, is an internationally recognized authority in aerosol drug delivery and respiratory function.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/donovan-yeates\/","og_locale":"en_US","og_type":"article","og_title":"Donovan Yeates &#8226; BioTech Pharma Summit","og_description":"Donovan B. Yeates, Ph.D., CEO, KAER Biotherapeutics Corporation, is an internationally recognized authority in aerosol drug delivery and respiratory function.","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/donovan-yeates\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2023-05-03T21:11:46+00:00","og_image":[{"width":900,"height":900,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Donovan_Yeates_Kaer_Biotherapeutics_BioTech_Pharma_summit.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/donovan-yeates\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/donovan-yeates\/","name":"Donovan Yeates &#8226; BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/donovan-yeates\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/donovan-yeates\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Donovan_Yeates_Kaer_Biotherapeutics_BioTech_Pharma_summit.jpg","datePublished":"2020-08-27T11:41:42+00:00","dateModified":"2023-05-03T21:11:46+00:00","description":"Donovan B. Yeates, Ph.D., CEO, KAER Biotherapeutics Corporation, is an internationally recognized authority in aerosol drug delivery and respiratory function.","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/donovan-yeates\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/donovan-yeates\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/donovan-yeates\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Donovan_Yeates_Kaer_Biotherapeutics_BioTech_Pharma_summit.jpg","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/08\/Donovan_Yeates_Kaer_Biotherapeutics_BioTech_Pharma_summit.jpg","width":900,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/donovan-yeates\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"Inhalation &#038; Respiratory Drug Delivery 2019 Speakers","item":"https:\/\/www.biotechpharmasummit.com\/index.php\/inhalation-respiratory-drug-delivery-2019-speakers\/"},{"@type":"ListItem","position":3,"name":"Donovan Yeates"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow&#039;s healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/33707","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=33707"}],"version-history":[{"count":6,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/33707\/revisions"}],"predecessor-version":[{"id":38311,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/33707\/revisions\/38311"}],"up":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/33607"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/33708"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=33707"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}